---
content_type: page
title: Readings
uid: cb25c623-fab8-e4a0-93bf-a60c4604b28b
---

This page presents various outlines, notes, textbook selections, and journal articles assigned for some class sessions.

TORA = Yannas, I. V. _Tissue and Organ Regeneration in Adults_. New York, NY: Springer-Verlag, 2001. ISBN: 9780387952147.

| LECÂ # | TOPICS | READINGS |
| --- | --- | --- |
| {{< td-colspan 3 >}}**I. Principles Of Implant Design (Working Paradigms)**{{< /td-colspan >}} |||
| 1 | Clinical Problems Requiring Implants for Solution |  {{< br >}}{{< br >}} Chapter 1 Outline ([PDF]({{< baseurl >}}/resources/ch1_outline)) {{< br >}}{{< br >}} TORA. Chapter 1. {{< br >}}{{< br >}}  |
| 2 | Principles of Implant Design / Design Parameters: Permanent versus Absorbable Devices | Chapter 2 Outline ([PDF]({{< baseurl >}}/resources/ch2_outline)) |
| 3 | The Missing Organ and its Replacement | TORA. Chapter 1. |
| 4 | Criteria for Materials Selection | TORA. Chapter 1. |
| 5 | Tissue Engineering I: Scaffolds | Langer, Robert, and Joseph P. Vacanti. "Tissue Engineering." _Science, New Series_ 260, no. 5110 (May 14, 1993): 920-926. |
| 6 | Tissue Engineering II: Cells and Regulators | &nbsp; |
| 7 | Case Study of Organ Regeneration |  {{< br >}}{{< br >}} TORA. Chapters 6, 7, and 10. {{< br >}}{{< br >}} Yannas, I. V., et al. "Wound Tissue Can Utilize a Polymeric Template to Synthesize a Functional Extension of Skin." _Science, New Series_ 215, no. 4529 (January 8, 1982): 174-176. {{< br >}}{{< br >}}  |
| {{< td-colspan 3 >}}**II. Design Parameters**{{< /td-colspan >}} |||
| 8 | Design Specifications: Biomaterials Survey | &nbsp; |
| &nbsp; | Quiz | &nbsp; |
| 9 | Biocompatibility: Local and Systemic Effects | &nbsp; |
| 10 | Design Specifications: Tissue Bonding and Modulus Matching | &nbsp; |
| 11 | Degradation of Devices: Natural and Synthetic Polymers | Spector, Myron. "Biomaterials." Chapter 19 in _Plastic Surgery_. Vol. 1. Edited by B. M. Achauer, et al. Mosby: St. Louis, 2000. ISBN: 9780815110194. |
| 12 | Biocompatibility: Scar Formation and Contraction | TORA. Chapters 1, 2, and 4. |
| 13 | Degradation of Devices: Corrosion and Wear | &nbsp; |
| 14 | Federal Regulation of Devices I |  {{< br >}}{{< br >}} FDA Guidance for Industry documents: {{< br >}}{{< br >}} E6 Good Clinical Practice: Consolidated Guidance ([PDF]({{< baseurl >}}/resources/ch9_fda_clinical)) {{< br >}}{{< br >}} E10 Choice of Control Group and Related Issues in Clinical Trials ([PDF]({{< baseurl >}}/resources/ch9_fda_controls)) {{< br >}}{{< br >}} [Tripartite Biocompatibility for Medical Devices](http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/default.htm) {{< br >}}{{< br >}}  |
| 15 | Oral Presentations of Proposals for Design II | &nbsp; |
| 16 | Federal Regulation of Devices II | [What is CE Marking?](http://www.ce-marking.org/what-is-ce-marking.html) |
| {{< td-colspan 3 >}}**III. Design Solution In-use**{{< /td-colspan >}} |||
| 17 | Scaffolds for Cartilage Repair | &nbsp; |
| 18 | Implants for Bone | &nbsp; |
| 19 | Implants for Plastic Surgery | &nbsp; |
| 20 | Cardiovascular Prostheses: Heart Valves and Blood Vessels |  {{< br >}}{{< br >}} Mitchell, L. Shannon, and Laura E. Niklason. "Requirements for Growing Tissue-Engineered Vascular Grafts." _Cardiovascular Pathology_ 12 (2003): 59-64. {{< br >}}{{< br >}} Niklason, L. E., J. Gao, W. M. Abbot, K. K. Hirschi, S. Houser, R. Marini, and R. Langer. "Functional Arteries Grown in Vitro." _Science_ 284 (April 16, 1999): 489-493. {{< br >}}{{< br >}} Schoen, Frederick J., and Robert J. Levy. "Tissue Heart Valves: Current Challenges and Future Research Perspectives." Founder's Award, 25th Annual Meeting of the Society for Biomaterials, Providence, RI, April 28-May 2, 1999. {{< br >}}{{< br >}} Rabkin, Elena, and Frederick J. Schoen. "Cardiovascular Tissue Engineering." _Cardiovascular Pathology II_ (2002): 305-317. {{< br >}}{{< br >}}  |
| 21 | Devices for Nerve Regeneration | TORA. Chapter 6. |
| 22 | Musculoskeletal Soft Tissues: Meniscus, Intervertebral Disk | &nbsp; |
| 23 | Dental and Otologic Implants | &nbsp; |
| 24 | Other Devices: Spinal Cord, Heart Lung | &nbsp; |
| 25 | Final Oral Presentation of Designs (Mock FDA Panel) |